Home › Lupus Nephritis › Texas
Lupus Nephritis clinical trials in Texas
12 studies for Lupus Nephritis are looking for participants at sites in Texas.
Cities in Texas
Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
- Baylor College of Medicine, Houston
RecruitingPhase 1
Ages 18 to 60 · All sexes · Updated Sep 14, 2026 · NCT06975787The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
- Baylor College of Medicine Pediatric Immunology Allergy Rheumatology, Houston
RecruitingPhase 2
Ages 8 to 20 · All sexes · Updated Sep 14, 2026 · NCT05538208A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
- The University of Texas Southwestern Medical Center, Dallas
RecruitingPhase 2
Ages 12 to 70 · All sexes · Updated Sep 14, 2026 · NCT07570862RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- University of Texas MD Anderson Cancer Center, Houston
RecruitingPhase 1/2
Ages 18 to 65 · All sexes · Updated Aug 26, 2026 · NCT06121297Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
- Texas Transplant Institute, San Antonio
RecruitingPhase 2
Ages 12 to 65 · All sexes · Updated Aug 24, 2026 · NCT07053800PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
- Novel Research LLC, Bellaire
- Liberty Research Center, Dallas
- Texas Arthritis Center, El Paso
- and 5 more
RecruitingPhase 4
Ages 18 to 75 · All sexes · Updated Aug 3, 2026 · NCT07611214Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- Prolato Clinical Research Center, Houston
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Jul 30, 2026 · NCT05268289A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
- Rheumatology Care Center, PLLC, Bellaire
- Texas Arthritis Center, El Paso
- Novel Research, LLC., Houston
- and 3 more
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Jul 30, 2026 · NCT07201129A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
- Nkarta Investigational Site, Dallas
- Nkarta Investigational Site, Houston
RecruitingPhase 1/2
Ages 18 to 75 · All sexes · Updated Jun 4, 2026 · NCT06557265Lupus Landmark Study: A Prospective Registry and Biorepository
- UT Southwestern Medical Center, Dallas
RecruitingObservational study
Ages 18 to 110 · All sexes · Updated Apr 15, 2026 · NCT05934149Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
- MD Anderson Cancer Center, Houston
- The University of Texas Health Science Center at Houston, Houston
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Apr 15, 2026 · NCT06434363Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial
- AARA Clinical Research, Fort Worth
RecruitingPhase 4
Ages 18 to 80 · All sexes · Updated Nov 6, 2025 · NCT07225387From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.